"Sleeping all day in your pajamas!": More on Rozerem’s marketing

November 1, 2006

Pharma Marketing Blog talks about Rozerem’s big marketing push, and wonders how such ludicrous displays passes FDA regulation:

BTW, how are little promos like this on medical conference sites sponsored by CME providers like M|C Communications — host of the Pri-Med Conference — regulated by the FDA? For example, the benefit statement above is not balanced by risk information, nor is there any link on this page to the package insert or to the Rozerem Web site where the physician can see the PI.

Perhaps M|C Communications will claim that they wrote the promo, not Takeda and the FDA has no jurisdiction over what it can say. Yeah, right!



Related posts:

  1. Those stupid Rozerem ads
  2. Rozerem: Marketing costs exceeds revenues
  3. Pfizer’s Adwords run afoul of FDA regulations
  4. More stupid Rozerem ads
  5. Multiple sclerosis simulator: A marketing ploy?
  6. Newsflash: Sleeping medications are being overprescribed
  7. Subliminal pharma marketing on Scrubs


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



Comments on this entry are closed.

Previous post: Surprise! Tobacco-sponsored anti-smoking ads don’t work

Next post: Generics killing Big Pharma

Site Meter